SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019738
Filing Date
2021-08-13
Accepted
2021-08-13 16:31:23
Documents
45
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 864138
2 ex31-1.htm EX-31.1 8270
3 ex31-2.htm EX-31.2 8223
4 ex32.htm EX-32 5793
  Complete submission text file 0001493152-21-019738.txt   4109602

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE amrh-20210630.xsd EX-101.SCH 32780
6 XBRL CALCULATION FILE amrh-20210630_cal.xml EX-101.CAL 33882
7 XBRL DEFINITION FILE amrh-20210630_def.xml EX-101.DEF 161883
8 XBRL LABEL FILE amrh-20210630_lab.xml EX-101.LAB 295478
9 XBRL PRESENTATION FILE amrh-20210630_pre.xml EX-101.PRE 220112
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 642280
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 211172662
SIC: 2834 Pharmaceutical Preparations